Introduction
============

*Helicobacter pylori* is a Gram-negative bacterium that infects the stomachs of approximately half the human population. Although infection is typically asymptomatic throughout the lifetime of the host, it causes peptic ulcer disease in about 10% of those infected and gastric adenocarcinoma in about 1--3% (Kusters et al., [@B15]). The best-studied bacterial factor associated with clinical sequelae of *H. pylori* infection is the cytotoxin associated gene pathogenicity island (*cag* PAI). Patients infected with *H. pylori* strains that contain the *cag* PAI are at increased risk for both peptic ulcer and gastric cancer (Kusters et al., [@B15]). Experimental studies in gerbils (Rieder et al., [@B19]), mice (Arnold et al., [@B3]), and rhesus macaques (Hornsby et al., [@B12]) have also demonstrated the pro-inflammatory effects of the *cag* PAI.

The 40-kb *cag* PAI contains on average 27 genes, several of which encode a type IV secretion apparatus that is required for translocation of the effector molecules CagA (*cag26*) and peptidoglycan into host epithelial cells (Segal et al., [@B23]; Odenbreit et al., [@B16]; Rohde et al., [@B20]; Viala et al., [@B29]). Of the 27 genes on the *cag* PAI, 18 are required for the translocation of CagA into host cells and 15 are required to induce transcription of the pro-inflammatory cytokine IL-8 (Fischer et al., [@B10]; Shaffer et al., [@B25]). CagA is reliant on the secretion chaperone protein CagF (*cag22*) for recruitment to the type IV translocation channel (Pattis et al., [@B17]). Upon translocation into the cell, CagA is phosphorylated at C-terminal tyrosine residues by c-Src and other kinases, which results in the activation of receptor tyrosine kinase (RTK)-like signaling pathways (Segal et al., [@B23]; Selbach et al., [@B24]). Both phosphorylated and unphosphorylated CagA contribute to *H. pylori* pathogenesis via multiple mechanisms, including the disruption of the cytoskeleton, interruption of cellular signaling, and interference with adhesion between adjacent cells (Backert and Selbach, [@B4]).

Several studies have provided a glimpse of the *cag* PAI transcriptional unit organization. One initial study employed a urease transcription fusion to check for promoters in nine *cag* PAI DNA regions that were upstream of groups of co-directional genes (Joyce et al., [@B13]). This analysis determined that there were at least five promoters on the *cag* PAI. Another early study identified the promoters responsible for regulating *cagA* and *cagB* (Spohn et al., [@B27]). A more recent genome-wide transcriptional unit analysis that used RNA sequencing identified 14 transcriptional units within the *cag* PAI. Additionally, they found many potential small regulatory RNAs (Sharma et al., [@B26]). Other studies have suggested that several *cag* PAI genes are differentially regulated *in vivo* compared to *in vitro* (Joyce et al., [@B13]; Boonjakuakul et al., [@B5]; Castillo et al., [@B9]). In one such study, an *in vivo* induced promoter called P*ivi66*, was internal to the *cag7* gene (Castillo et al., [@B9]), which suggested that promoters may not always be within intergenic regions.

Here we sought to determine the conservation of operon structure in the *cag* PAI among *H. pylori* strains, and to identify promoters responsible for the transcription of *cag* PAI genes in strains 26695, J99, and G27, whose genomes are sequenced (Tomb et al., [@B28]; Alm et al., [@B1]), and in strain J166 that we and others have used to infect rhesus macaques (Hornsby et al., [@B12]). Operon structure was first predicted by a gene expression analysis that used quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) for both open reading frames (ORFs) and intergenic regions. The predicted putative operons were further defined by qRT-PCR after deletion of selected promoter regions. Since our transcription analyses suggested a potentially complex operon structure, we augmented these studies with a non-biased promoter-trap study that identified *cag* PAI promoters as DNA regions capable of directing expression of a heterologous reporter. Our results demonstrate that there is remarkable consistency across strains in the expression of genes in the *cag* PAI, which is organized into at least 20 transcriptional units.

Materials and Methods {#s1}
=====================

Bacterial strains and culture
-----------------------------

*Helicobacter pylori* strains 26695 (Tomb et al., [@B28]), J99 (Alm et al., [@B1]), J166 (Hornsby et al., [@B12]), and ACHP17 (mG27 *HP0294/295::res1-aphA3-res1*; Castillo et al., [@B8]) were used for these studies. DNA and RNA for qRT-PCR were prepared from strains cultured on *Brucella* agar (Difco Laboratories, Detroit, MI, USA) containing 5% bovine calf serum (Invitrogen Life Technologies, Carlsbad, CA, USA) supplemented with 5 μg/mL trimethoprim, 10 μg/mL vancomycin, 2.5 IU/mL polymixin B, 2.5 μg/mL amphotericin B (TVPA, all from Sigma, St. Louis, MO, USA) and incubated at 37°C with an atmosphere that contained 5% CO~2~. Plate grown bacteria were then transferred to *Brucella* broth containing bovine calf serum with TVPA and incubated at 37°C in 5% CO~2~ with gentle rotation at 60 rpm. The OD~600~ was determined for each culture 18--24 h after inoculation. The promoter reporter *H. pylori* strain ACHP17 and strain G27 from which RNA was isolated for RT-PCR were grown under microaerobic conditions (10% CO~2~, 5% O~2~, and 85% N~2~) at 37°C on columbia blood agar plates with 4% (w/v) columbia agar base, 5% (w/v) defibrinated horse blood (Hemostat labs), 0.2% (w/v) β-cyclodextrin, 10 μg/mL vancomycin, 50 μg/mL cycloheximide, 5 μg/mL cefsulodin, 8 μg/mL amphotericin B, 2.5 IU/mL polymyxin and 5 μg/mL trimethoprim. *H. pylori* strains were stored at −80°C in brain heart infusion media supplemented with 10% fetal bovine serum, 1% (w/v) β-cyclodextrin, 25% glycerol, and 5% dimethyl sulfoxide.

*Escherichia coli* strain DH10B (Grant et al., [@B11]) was grown at 37°C in Luria--Bertani (LB) broth (1% w/v tryptone, 0.5% w/v yeast extract, 0.5% w/v NaCl), with 100 μg/mL ampicillin. *E. coli* was also grown on solid LB media consisting of LB broth with 1.5% (w/v) agar. All antibiotics were purchased from Sigma-Aldrich, Fisher, or ISC BioExpress. All culture media were purchased from Remel, Fisher, or Difco unless otherwise indicated.

RNA and DNA extraction
----------------------

At OD~600~ 0.4--0.5 (early exponential growth phase) 2 mL aliquots were taken from *H. pylori* liquid cultures and centrifuged at 16,000 × *g* for 30 s at room temperature. Supernatants were removed and 1 mL of TriZol (Invitrogen) was immediately added. Samples were vortexed and RNA was extracted according to the manufacturer's directions. RNA was treated with DNase I (Roche Applied Sciences, Mannheim, Germany), purified using an RNeasy clean up kit (QIAGEN, Inc., Valencia, CA, USA), and suspended in ultra pure water (Invitrogen) at a concentration of 20 ng/μL.

DNA was extracted from plate grown bacteria using a DNeasy Tissue Kit (QIAGEN). DNA samples were diluted in ultra pure water to a concentration of 5 ng/μL and stored at −20°C.

RT-PCR to detect promoters, PIII, PIX, and PXII
-----------------------------------------------

Reverse-transcriptase polymerase chain reactions were carried out using the Super Script One-step RT-PCR kit with Platinum Taq (Invitrogen). One hundred or 250 ng of RNA was used as a template for each RT-PCR reaction. For the reverse-transcription step (55°C for 30 min), only the oligonucleotide that was complementary to the putative transcript was included in the reaction, PIIIR (5′-cctagcgaccaaaagcgatgaa-3′), PIXR (5′-gaaactgctaagaatatcagtg-3′), and PXIIR (5′-cgtcattaatcaaatagaacaaagc-3′). The reverse-transcriptase in these reactions was then inactivated by incubation at 94°C for 5 min. Prior to starting the PCR program (35 cycles, 94°C/30 s, 55°C/30 s, 72°C/30 s) the reactions were briefly incubated on ice (∼1 min) while the second oligonucleotides, PIIIF (5′-cattgtggtctttcccgaaagc-3′), PIXF (5′-cactcttgcctataaaggcc-3′), and PXIIF (5′-ctgagacgacaagctatgatttc-3′) were added. Oligonucleotides for our positive control were HP188F (5′-ccactataaaagagatctttcaagcggaagg-3′) and HP187R (5′-gcttgccctcggtgtctgcatc-3′); HP187R was present in the RT reaction and both HP187R and HP188F were present in the PCR reaction. As a control for amplification, each set of oligonucleotides was used in a PCR reaction with DNA as the template. Additionally, each set of oligonucleotides was used in an RT-PCR reaction with the RNA template and Platinum Taq only. This control was done to verify our RNA samples were DNA free.

qRT-PCR and agarose gel electrophoresis
---------------------------------------

Quantitative real time RT-PCR was performed with primer pairs specific for each *cag* gene (Table [A1](#TA1){ref-type="table"} in Appendix) and for each intergenic region (Table [A2](#TA2){ref-type="table"} in Appendix), using methods essentially as described (Boonjakuakul et al., [@B6], [@B5]). In brief, RT and PCR were performed in a single 20 μL reaction mixture using the thermostable recombinant *Tth* (r*Tth*) DNA polymerase (Applied Biosystems) with 100 ng RNA extracted as described above. In the presence of Mn(OAc)~2~, r*Tth* has reverse-transcriptase activity and DNA polymerase activity. Two-step amplification was performed with 45 cycles at 95°C for 20 s followed by 59.5°C for 1 min. Accumulation of PCR product was detected during each cycle by excitation of SYBR green at 490 nm. Relative fluorescence was characterized by a cycle threshold (*C*t) value, which was defined as the crossover point of the kinetic curve with an arbitrary fluorescence level set at 150 relative fluorescence units. The absence of contaminating DNA was examined by performing the RT-PCR with MgCl~2~, in which r*Tth* has DNA polymerase but no RT activity. All qRT-PCR products were electrophoresed on a 2% agarose (Invitrogen) gel to verify correct product size. Transcript abundance was calculated only if the observed *C*t with RNA template was less than that of the no-template control, and there was a band of the appropriate size on an agarose gel. Otherwise, transcript was considered absent. All transcript copy numbers were normalized to 16S RNA and the data presented represents the average of duplicate wells.

Construction of *cag* PAI promoter deletion mutants
---------------------------------------------------

The chloramphenicol resistance conferring *cat* gene from plasmid pNR9589 (Wang and Taylor, [@B30]) and 1--2 kb DNA fragments of the genes directly flanking the region targeted for deletion were PCR amplified (oligonucleotides in Table [A3](#TA3){ref-type="table"} in Appendix) with compatible restriction sites. All three fragments were digested with the appropriate enzymes and ligated with compatibly digested pBluescript SK− (Stratagene, La Jolla, CA, USA) to generate a shuttle plasmid with fragments of the *cag* PAI flanking the *cat* gene. The shuttle plasmid was amplified in *E. coli* Top10 (Invitrogen, Carlsbad, CA, USA), sequence verified, and then used to transform *H. pylori* strain J166 by a standard natural transformation procedure (Salama et al., [@B21]). *H. pylori* transformants were selected on *Brucella* agar plates with TVPA and 4 μg/mL chloramphenicol. Correct replacement of *cag* PAI DNA regions with the *cat* gene was verified using PCR and DNA sequence analyses.

Generating the *H. pylori* *cag* PAI library of putative promoters
------------------------------------------------------------------

Genomic DNA was isolated from *H. pylori* J166 and mG27 (Wizard genomic prep kit, Promega). The DNA region representing the *cag* PAI was amplified from each strain as a set of 13 PCR products of ∼2.5 kb in length with 600 bp of overlap between adjacent PCR products (oligonucleotides in Table [A4](#TA4){ref-type="table"} in Appendix). For each strain, the PCR products were pooled, partially digested with *Sau3A*, and ligated to *Bgl*II digested p*cat-T-*tnpR (Castillo et al., [@B8]) to generate recombinant plasmids, p*cat-T-caglibmG27-tnpR* and p*cat-T-caglibJ166-tnpR*. After ligation, the recombinant plasmids were transformed into *E. coli* DH10B and the *E. coli* were plated on LB agar with ampicillin. For these strains, ∼2193 (p*cat*-*T-caglibmG27-tnpR*) or 5000 (p*cat*-*T-caglibmJ166-tnpR*) individual ampicillin resistant (Amp^R^) colonies were pooled, grown overnight, and treated (Qiagen miniprep extraction kit, Qiagen) to extract the recombinant plasmids. For a subset of colonies from each library, individual recombinant plasmids were analyzed for the presence and size of a *H. pylori* cag PAI insert. All recombinant plasmids analyzed contained inserts and had an average insert size of 469 bp for p*cat-T-caglibmG27-tnpR* and 96 bp for p*cat-T-caglibmJ166-tnpR*.

To isolate putative promoters, *H. pylori* strain *ACHP17* was transformed using natural transformation (Salama et al., [@B21]) with either p*cat-T-caglibmG27-tnpR* or p*cat-T-caglibJ166-tnpR*, and transformants were selected based on their resistance to chloramphenicol (Cm) on CBA plus 13 μg/mL Cm. Cm resistant (Cm^R^) transformants were passed twice on Cm prior to being analyzed for kanamycin sensitivity (Km^S^) on CBA plus 15 μg/mL kanamycin.

To examine the diversity of the *cag* PAI library clones in *H. pylori*, 10--30 Cm^R^ clones were selected from each library and the region upstream of *tnpR* was sequenced using primers rrnB1 and tnpRbk75 (Castillo et al., [@B8]). The average insert size was 232 bp for p*cat-T-caglibmG27-tnpR* and 100 bp for p*cat-T-caglibJ166-tnpR*. PCR amplicons were sequenced and compared to the 26695 and G27 genomes to assess randomness of the cloned regions. The number of transformants needed to obtain 100% coverage of the *cag* PAI for each library was determined using the formula *N* = ln\[1 − *P*/ln(1 − I/G)\] (*N* = number of independent clones, I = size of averaged cloned fragment, G = size of target genome, and *P* = probability). These calculations suggested that 791 p*cat-T-caglibmG27-tnpR* and 1840 p*cat-T-caglibJ166-tnpR* transformants would be required for complete coverage of the *cag* PAI.

Results
=======

We used both transcription profiling and a functional genetic approach to define *cag* PAI operons and the putative promoters that regulate them. First, we performed qRT-PCR to determine the mRNA copy number within each ORF and each intergenic region on the *cag* PAI. Our assumption was that contiguous genes transcribed in the same direction, with the presence of intergenic message and similar mRNA copy number, would likely form an operon. Selected putative operons were then further analyzed by deletion of the promoter region and reanalysis of mRNA copy number of downstream genes. We then augmented these analyses by using a non-biased promoter-trap system to find active promoters within the *cag* PAI.

Co-expression of *cag* PAI genes based on gene and intergenic transcript copy number
------------------------------------------------------------------------------------

We first calculated the transcript copy number for each gene and intergenic region within the *cag* PAI of *H. pylori* J99, 26695, and J166, using methods described previously (Boonjakuakul et al., [@B6], [@B5]). Briefly, three factors were used to calculate copies per cell: (a) a 10-fold change in starting template concentration corresponds to a 3.3-cycles change in *C*t (2^3.3^ = 10); (b) 100 ng of RNA equals 10^6^ *H. pylori* cells, and (c) the empirically derived observation that a *C*t of 19 corresponds to 1 × 10^5^ copies of starting DNA template (assuming 1 copy per bacterial chromosome). We have previously shown that calculation of mRNA copies/cell using *C*t corrected for primer efficiency yields values that are essentially identical to those obtained by the more conventional method using standard curves (Boonjakuakul et al., [@B6]).

Transcript levels for all genes on the *cag* PAI for each *H. pylori* strain are shown in Figure [1](#F1){ref-type="fig"}. For clarity, intergenic transcript is shown only as present (adjacent bars representing gene transcript levels are shaded identically) or absent (adjacent bars are shaded differently). For example, intergenic transcript was detected between *cag1* and *cag2* (both black bars) and between *cag10* and *cag9* (both gray bars), but not between *cag15* (gray bar) and *cag14* (black bar). Transcript levels varied within each strain by as much as five orders of magnitude, ranging from about 10 copies/cell to as low as 1 copy per 10,000 cells. These estimates are consistent with our previous studies (Boonjakuakul et al., [@B6], [@B5]) and with estimates of gene expression levels in *Saccharomyces cerevisiae* (Kang et al., [@B14]) and *E. coli* (Young and Bremer, [@B31]). The highest transcript abundance was found for *cag26* and for *cag25*. Since *cag26* encodes an effector protein, CagA, secreted via the type IV secretion system, and *cag25* encodes a virB2 ortholog that is thought to encode a pilin protein that forms a multimeric structure (Andrzejewska et al., [@B2]), it is not surprising that these genes are highly expressed. Although in general, the expression level of genes on the *cag* PAI was similar across the three strains analyzed, there is some variation that appears to occur within the operons predicted by these experiments (Figure [2](#F2){ref-type="fig"}).

![**Expression level of each gene on the *cag* PAI (mRNA copies/cell; normalized to 16S rRNA) for *H. pylori* strains J166 (top panel), J99 (middle panel), and 26695 (bottom panel)**. Our data represents the average of duplicate reactions. Adjacent genes for which intergenic transcript was detected are indicated with the same shading (black or gray). Direction of transcription is shown by arrowheads below the bottom panel. Since *cag26* (*cagA*) is not contiguous with the PAI in *H. pylori* J166, the *cag25-26* intergenic message was not measured, but presumed to be absent because *cag25* and *cag26* transcription is in opposite directions.](fcimb-02-00046-g001){#F1}

![**Composite gene expression (mRNA copies/cell, normalized to 16S rRNA) for each gene on the *cag* PAI of *H. pylori* strains J166 (open circles), J99 (closed circles), and 26695 (open triangles)**. Our data represents the average of duplicate reactions.](fcimb-02-00046-g002){#F2}

We reasoned that adjacent genes transcribed with ORFs in the same direction, with the presence of intergenic transcript, might represent a single transcriptional unit, particularly if the transcript abundance was similar across genes. Therefore, we initially considered the possibility that the following may represent *cag* PAI operons (numbered in the direction of transcription): *cag1-4*, *cag10-5*, *cag11-12*, *cag16-17*, *cag21-18*, and *cag25-22* (Figure [1](#F1){ref-type="fig"}). However, there were sometimes marked differences in transcript abundance of genes within these putative operons (e.g., *cag25-22*, Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). This might occur due to differential decay of the transcript or possibly because the gene is part of more than one transcriptional unit. To address these possibilities, we deleted the genomic region immediately upstream of the translational start of the first gene in each of six putative operons in *H. pylori* strain J166, a region likely to contain the promoter, and then measured *cag* PAI gene transcript abundance. We reasoned that deletion of this region should decrease the expression level of all genes in the transcriptional unit, and leave others unchanged.

Deletion of the putative promoter regions upstream of *cag1*, *cag10*, *cag11*, *cag16*, *cag21*, and *cag25* had differential effects on the expression of downstream genes when compared to the isogenic wild type *H. pylori* J166 strain (Figure [3](#F3){ref-type="fig"}). Deletion of the region upstream of *cag1* reduced expression of *cag1-3* by three orders of magnitude and *cag4* by only 1.5 orders of magnitude. By contrast, expression of *cag5*, a gene transcribed in the opposite direction of this putative operon, remained essentially unchanged. Deletion of the region upstream of *cag10* reduced expression of both *cag10* and *cag9* by similar levels and had no effect on expression of *cag8-7*. Deletion of the putative promoters upstream of *cag11*, *cag16*, and *cag21* reduced expression of the downstream genes, *cag11-12*, *cag16-17*, and *cag21-18*, but in each case to different levels, ranging from 1 to 3 orders of magnitude (Figure [3](#F3){ref-type="fig"}). Finally, deletion of the region upstream of *cag25* reduced expression of the downstream genes *cag25-23* to different levels and had no effect on the expression of *cag22*. In some cases, these results make clear predictions about operon structure. For example, our original prediction of *cag10-5* and *cag25-22* as operons was incorrect, since in each case one or more downstream genes did not change appreciably in the promoter knockouts. Thus, *cag10-5* consists of at least two operons, *cag10-9* and *cag8-7*, which also may be organized into one or more transcriptional units. Similarly, *cag25-22* appears to have only *cag25-24* on one transcriptional unit, with *cag22* and perhaps *cag23* on separate transcripts. The variable change we observed in *cag* PAI gene expression after deletion of the predicted upstream promoter again suggests that either the transcripts are being degraded or that there are additional promoters controlling expression of these genes. To identify additional promoters that may contribute to the more complex expression pattern we observed here, we undertook a non-biased promoter-trap approach.

![**Change in *cag* PAI gene expression (log 10 change mRNA) between wild type *H. pylori* J166 and isogenic deletions of DNA upstream of the translational start codon in *cag1* (416 bp, top left), *cag10* (498 bp, top right), *cag11* (498 bp, middle left), *cag16* (532 bp, middle right), *cag21* (615 bp, bottom left), and *cag25* (706 bp, bottom right)**. Filled arrows indicate direction of transcription and open arrows indicate putative operons.](fcimb-02-00046-g003){#F3}

Non-biased promoter-trap identifies additional *cag* PAI promoters
------------------------------------------------------------------

We next employed a functional identification of *cag* PAI promoters strategy based on the ability of short cloned regions of the *cag* PAI to direct expression of a heterologous promoter. We used a *tnpR* transcriptional reporter developed for *Vibrio cholerae* (Camilli et al., [@B7]) that had been previously modified to function in *H. pylori* (Camilli et al., [@B7]; Castillo et al., [@B9]). We constructed libraries of putative *cag* PAI promoters using both *H. pylori* strains J166 and G27 as template for PCR; we cloned the Sau3A-digested fragments upstream of the promoterless *tnpR* gene in p*CT-tnpR*. If the cloned *cag* PAI region contained a promoter, we predicted it would direct *tnpR* expression and the creation of the TnpR protein. TnpR in turn would catalyze the removal of an unlinked kanamycin resistance (Km^R^) cassette and convert the *H. pylori* reporter strain ACHP17 from Km^R^ to Km^S^.

For promoter identification, *H. pylori* strain ACHP17 bearing the *res1-kan-res1* marker was transformed with p*cat-T-caglibmG27-tnpR* or p*cat-T-caglibJ166-tnpR* to Cm^R^, followed by screening for retention or loss of the *res1-kan-res1* cassette. We screened 1060 *H. pylori* p*cat-T-caglibmG27-tnpR* transformants and 1274 *H. pylori* p*cat-T-caglibmJ166-tnpR* transformants, representing 100 and 71% coverage, respectively. This analysis identified 34 and 27 transformants, respectively, that were sensitive to kanamycin and thus had expressed *tnpR*. After removing redundant clones, we determined that the DNA sequences upstream of *tnpR* in these Km^S^ transformants correspond to 14 unique loci (Table [1](#T1){ref-type="table"}). Eleven and four promoters were identified through the screening of our p*cat-T-caglibmG27-tnpR* and p*cat-T-caglibmJ166-tnpR* libraries, respectively; one promoter, PIII (Table [1](#T1){ref-type="table"}; Figure [4](#F4){ref-type="fig"}), was isolated from both libraries.

###### 

**Chromosomal location of putative *cag* PAI promoters**.

  Putative promoter (length; nt) ± strand   Cag PAI library, genome source   G27 genome position   26695 genome position   Sharma et al. ([@B26])^a^, transcription start site (TSS)   Joyce et al. ([@B13])^b^   This study^c^
  ----------------------------------------- -------------------------------- --------------------- ----------------------- ----------------------------------------------------------- -------------------------- ---------------
  I (244)−                                  G27                              542756-542513         574379-574136           TSS575200−                                                  Y                          Y (P)
  II (38)+                                  G27                              530249-530286         563751-563788           TSS564140+                                                  Y                          Y (P)
                                                                                                                           TSS564347+                                                                             
  III (91)+                                 G27 and J166                     544137-544227         575760-575850           None                                                        N                          N
  IV (104)+                                 G27                              515270-515371         548689-548790           TSS549427+                                                  N                          Y (T)
  V (71)−                                   G27                              547735-547665         579357-579287           TSS579114−                                                                             Y (P)
  VI (314)+                                 G27                              514575-514888         547996-548307           None                                                        N                          N
  VII (234)−                                G27                              525984-525661         558996-558763           None                                                        N                          N
  VIII (635)−                               G27                              530667-530918         564409-563785           TSS564078−                                                  Y                          Y (P)
                                                                                                                           TSS564329−                                                                             
  IX (132)+                                 G27                              521375-521506         554800-554931           None                                                        N                          N
  X (269)−                                  G27                              528142-527874         561644-561372           TSS561595−                                                  N                          Y (T)
  XI (419)+                                 G27                              547665-548083         579287-579744           TSS579817+                                                  N                          N
  XII (54)−                                 J166                             539314-539259         570937-570882           None                                                        N                          N
  XIII (68)−                                J166                             546797-546736         578420-578359           None                                                        N                          Y (T)
  XIV (70)+                                 J166                             548866-548927         580539-580604           None                                                        ND                         N

*^a^Transcription start sites (TSS) predicted by Sharma et al. ([@B26]) that are downstream of, or within, the promoter-trap-identified promoter. The 26695 genomic position and DNA strand (+ or −) of the TSS are indicated. None, no TSS near the functionally identified promoter. ^b^Y, promoter was previously identified by Joyce et al. ([@B13]). N, promoter was not previously identified by Joyce et al. ([@B13]). ^c^P, the promoter-trap-identified promoter was within the genomic region deleted in our promoter deletion analysis; T, it is in a location that is consistent with the changes we observe in *cag* gene expression; N, it was not within a genomic region deleted in our promoter deletion analysis or indicated by changes in *cag* PAI gene expression*.

![**Promoter-trap-identified promoters and proposed transcript map on the *H. pyloricag* PAI**. Each gene on the *cag* PAI is represented by a thick black arrow, oriented in the direction of transcription, whose length and spacing are approximately proportional to the annotated gene length and intergenic spacing. DNA segments represented in the promoter library that contained functional promoters (numbered I--XIV) to correspond with Table [1](#T1){ref-type="table"} and sequences in Table [A5](#TA5){ref-type="table"} in Appendix) are shown as small gray flags pointing in the direction they direct transcription and positioned in their *cag* PAI location. Thin black arrows represent 17 of the 20 proposed transcripts and gray arrowheads represent the three potential antisense transcript start points. All arrows point in the direction of transcription. Transcription start sites identified in Sharma et al. ([@B26]) are indicated by an asterisk (~\*~); black asterisks indicate the transcription start site is on the plus strand and gray asterisks indicate the minus strand.](fcimb-02-00046-g004){#F4}

Promoter-trap-identified promoters
----------------------------------

We next mapped our promoter-trap-identified promoters onto the *cag* PAI map and compared these promoters to those found in by our initial qRT-PCR analysis and also to the work of others. Several of the promoter-trap-identified promoters were located in *cag* PAI regions that were either predicted by the qRT-PCR or promoter deletion analyses (Table [1](#T1){ref-type="table"}). These include the promoters upstream of *cag10* (PVIII), *cag11* (PII), *cag 21* (PI), and *cag25* (PV; Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}; Table [1](#T1){ref-type="table"}). The promoter-trap approach also identified several possible promoters that were located within operons that might account for the variable gene expression observed after deleting the main promoter (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). These include PIV, PX, and PXIII that are located in genomic positions to suggest they contribute to the expression of *cag4*, *cag8-7*, and *cag23-22* (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}).

The other putative promoters identified in our promoter-trap study are either consistent with *cag* PAI transcripts predicted by other groups, or as of yet, unique. We identified a promoter that is upstream of *cag26* (PXI) and one that is within, and in the same direction as, *cag26* (PXIV). The promoter upstream of *cag26* was identified in work done by Spohn et al. ([@B27]) and more recently by Sharma et al. ([@B26]) as a promoter that drives expression of *cag26* (Figure [4](#F4){ref-type="fig"}; Spohn et al., [@B27]; Sharma et al., [@B26]). We also identified a unique putative promoter (PVI) that overlaps *cag3* and the adjacent upstream region and is in the correct direction to promote expression of a polycistronic mRNA including *cag3* and *cag4* (Figure [4](#F4){ref-type="fig"}). Two of our putative promoters were located within *cag7*, one in the same direction (PVII) and one antisense (PIX) to *cag7* (Figure [4](#F4){ref-type="fig"}). We hypothesize the promoter located within *cag7* contributes to expression of *cag6-5* and the promoter that is antisense to *cag7* may direct expression of a regulatory sRNA. Neither of these promoters has been identified by other studies. Finally, the last two putative promoters we identified, PIII and PXII, were within and antisense to *cag23* and in the 3′ end of *cag18* and may direct expression of sRNAs that are antisense to *cag23* and *cag17*, respectively. These promoters are also unique to this study.

Although our transcription, promoter deletion and promoter-trap analyses do not completely overlap, they show reasonable agreement in predicting transcripts and operon structure and are generally consistent with operon structure predicted by others (Table [1](#T1){ref-type="table"}, discussion). Taken together our data suggests the existence of at least 20 *cag* PAI transcripts (Figure [4](#F4){ref-type="fig"}).

PIII and PXII direct expression of antisense transcripts
--------------------------------------------------------

To determine if the promoters PIII, PIX, and PXII direct expression of transcripts that are antisense to *cag23*, *cag7*, and *cag17*, respectively, we carried out additional RT-PCR reactions on RNA isolated from *H. pylori* strain G27. The oligonucleotides (PIIIR, PIXR, and PXIIR) used in the reverse-transcription reactions were located ∼100--150 nt downstream of PIII, PIX, and PXII and were antisense to the putative transcripts. For the subsequent PCR reactions in which reverse-transcriptase had been inactivated, the sense oligonucleotides, PIIIF, PIXF, and PXII were added. Amplicons were detected downstream of PIII and PXII in the RT-PCR reactions and were absent in the corresponding polymerase only controls, suggesting that these promoters do in fact direct expression of transcripts (Figure [5](#F5){ref-type="fig"}). We did not detect a transcript downstream of PIX in our experiments; while it is possible that PIX is not a promoter, it is more likely that the transcript is regulated or is in very low abundance. The promoter-trap system by which PIX was identified was designed to capture low abundant and transient expression events.

![**Reverse-transcriptase polymerase chain reaction (RT-PCR) identifies transcripts downstream of promoter-trap-identified promoters PIII and PXII**. RT-PCR was carried out for the three promoters that potentially directed expression of antisense transcripts, PIII, PIX, and PXII. Three reactions were included for each promoter, a DNA template + DNA polymerase (DNA), an RNA template + DNA polymerase (T) and an RNA template + reverse-transcriptase and DNA polymerase (RT). Amplicons of the correct size were detected for PIII and PXII in the RT reactions but not in the T reactions. An amplicon was not detected for PIX in the RT or T reactions. This supports expression of transcripts downstream of PIII and PXII, but not PIX. The ~\*~ indicates the 100-bp marker of the 100-bp ladder.](fcimb-02-00046-g005){#F5}

Discussion
==========

In this study we used transcript profiling coupled with putative promoter deletion and a non-biased promoter-trap system to analyze expression of *cag* PAI genes and their organization into transcriptional units across several *H. pylori* strains. We found that *cag* PAI gene expression varies by nearly five orders of magnitude across the *cag* PAI, and that expression of *cag* PAI genes is similar across strains 26695, J99, and J166. Based on transcript profiling of *cag* PAI ORFs and intergenic regions, we initially placed *cag* PAI genes into six polycistrons and four monocistrons. However, subsequent promoter deletions coupled with transcript profiling and promoter-trap promoter identification studies suggested *cag* PAI operon structure was much more complex. Our data suggests that there are at least 11 operons: *cag1-4*, *cag3-4*, *cag10-9*, *cag8-7*, *cag6-5*, *cag11-12*, *cag16-17*, *cag19-18*, *cag21-20*, *cag23-22*, and *cag25-24*, as well as five monocistronic genes (*cag4*, *cag13*, *cag14*, *cag15*, *cag26*). Additionally, the location of four of our promoter-trap-identified promoters suggests they direct expression of, in one case, a truncated version of *cag26* and in the other three, transcripts that are antisense to *cag7*, *cag17*, and *cag23*. Using RT-PCR we verified the presence of transcripts that are antisense to *cag17* and *cag23*.

Conservation of *cag* PAI gene expression among *H. pylori* strains
-------------------------------------------------------------------

Our transcript profiling of *cag* PAI ORFs and intergenic regions of three *H. pylori* strains, 26695, J99, and J166, suggested that *cag* PAI expression is generally conserved among strains. There were some genes, however, whose expression showed appreciable differences across strains. Potential reasons for these differences may be attributed to one or a combination of the following: (1) difficulty in accurate quantitation of low abundance transcripts, (2) differential stability of the transcripts, and (3) differential strength of the promoters. We suspect that the differences in *cag15* expression between strains may be due to its very low expression *in vitro* (Joyce et al., [@B13]). The reduced expression of *cag12*, *cag13*, and *cag19* in *H. pylori* strain 26695 compared to that of J99 and J166 is more likely attributed to transcript instability and differences in promoter strength. Our expression findings should allow researchers to more confidently apply our and other *cag* PAI expression data to unique clinically isolated *H. pylori* strains.

Different studies predict similar *cag* PAI operon structure
------------------------------------------------------------

Our findings are generally consistent with previous predictions of *cag* PAI promoters, expression and operon structure. First, our promoter-trap and promoter deletion studies identified four of the five *cag* PAI promoters, upstream of *cag1*, *cag10*, *cag21*, and *cag25* (not *cag15*), that were predicted by Joyce et al. ([@B13]) in the *H. pylori* Alston strain. However our transcript profiling of *cag* PAI ORFs and intergenic regions did predict the promoter upstream of the *cag15* (Figure [1](#F1){ref-type="fig"}). The failure of our promoter-trap to identify the promoter upstream of *cag15* was not surprising, as Joyce et al. ([@B13]) found that this promoter was only induced in co-culture with epithelial cells or in mice. A similar profile of promoters between the clinically isolated Alston strain and 26695, J99, J166, and G27 again supports conservation of *cag* PAI operon structure and expression between *H. pylori* strains.

Our promoter analyses also identified promoters upstream of *cag25* (*cagB*) and *cag26* (*cagA*) that were in positions similar to those previously reported by Spohn et al. ([@B27]) for *H. pylori* strain G27, and by Sharma et al. ([@B26]) for *H. pylori* strain 26695. Spohn et al. ([@B27]) identified two transcription start points upstream of *cag25* that are ∼200 bp upstream of what we and Sharma et al. ([@B26]) found for *cag25*. All three studies predicted the same start point that is upstream of *cag26*, but we found an additional promoter that is located within *cag26*. The significance of multiple start sites upstream of *cag25* and within *cag26* are, as of yet, unclear. However, a recent study suggests discreet roles for the amino- and carboxy-terminus of Cag26 (CagA) and it is interesting to speculate this promoter could separate Cag26 function by creating a truncated protein (Pelz et al., [@B18]).

Our transcript profiles obtained from our work were also consistent with many of the 14 *cag* PAI operons identified in the *H. pylori* genome-wide transcript analysis conducted by Sharma et al. ([@B26]). In common, we predicted five polycistrons: *cag1-4*, *cag6-5*, *cag8-7*, *cag11-12*, and *cag16-17*, and the three monocistrons: *cag4*, *cag13*, and *cag26*. Our promoter locations are consistent with their transcripts that start at *cag10*, *cag14*, and *cag25*, but our data did not predict that the transcripts extended to *cag7*, *cag13*, and *cag18*, respectively. We also did not find functional promoters upstream of *cag17* and *cag18* that would suggest they were also expressed as monocistrons. However, in addition to the truncated *cag26* transcript mentioned above, we also identified the following set of transcripts that were not identified by Sharma et al. ([@B26]), including the polycistrons *cag3-4*, *cag21-20*, *cag19-18* and three transcripts that were antisense to *cag7*, *cag17*, and *cag23*. A transcript for *cag15* was also not identified by Sharma et al. ([@B26]), likely due to its very low abundance *in vitro* (Joyce et al., [@B13]). We speculate that these discrepancies are due to potential issues with transcript abundance and stability here and in Sharma et al. ([@B26]) and incomplete screening of our *cag* PAI promoter libraries.

Incomplete screening of *cag* PAI promoter libraries
----------------------------------------------------

Outstanding observations in our screening of the p*cat-T-caglibJ166-tnpR* and p*cat-T-caglibG27-tnpR* libraries in *H. pylori* ACHP17 were that we only identified four promoters grouped at the 3′-end of the *cag* PAI from p*cat-T-caglibJ166-tnpR* and that we did not identify promoters from the central region of the *cag* PAI from p*cat-T-caglibG27-tnpR*. We hypothesize that this was due to a combination of two things: (1) incomplete representation of the *cag* PAI region in both of our libraries and then (2) restriction modification system differences that were apparent in transforming our G27 based reporter strain ACHP17 with J166 *cag* PAI DNA. Although our library screening calculations (see [Materials and Methods](#s1){ref-type="sec"}) suggested that we had screened 100% of the *H. pylori* G27 *cag* PAI and 71% of the *H. pylori* J166 *cag* PAI, our control experiments with 10 or 30 randomly selected *H. pylori* transformants, respectively, suggested that our libraries were biased; the *H. pylori* *caglibG27-tnpR* library was biased toward the left and right ends of the *cag* PAI and the *H. pylori* *caglibJ166* library was biased toward the right side of the *cag* PAI. Nonetheless, this methodology was very effective at identifying promoters in positions where we observed slight differences in expression of adjacent genes. Specific amplification of *cag* PAI regions (e.g., *cag12-17*) that were underrepresented in our *cag* PAI libraries will ensure better representation of the G27 *cag* PAI region in our library for future *in vivo* analyses.

Comparing *cag* PAI expression *in vitro* and *in vivo*
-------------------------------------------------------

This and previous studies have contributed to building a more complete expression profile of the clinically important *cag* PAI of *H. pylori* grown *in vitro* (Spohn et al., [@B27]; Joyce et al., [@B13]; Sharma et al., [@B26]). The promoters identified by these *in vitro* studies can now be analyzed for their potential regulation during *H. pylori* infection of a host. It is clear in at least two cases that *in vitro* predicted promoters, those upstream of *cag15* and *cag21*, are expressed at higher levels when co-cultured with an epithelial cell monolayer and in mice (Joyce et al., [@B13]). While we anticipate that a subset of our *in vitro* identified promoters will be regulated *in vivo* and may contribute to virulence, other studies suggest that there is a set of promoters or transcripts uniquely expressed *in vivo* (Scott et al., [@B22]; Castillo et al., [@B9]); analysis of *H. pylori* transcripts isolated from gerbil stomachs predicted that *cag25* is expressed as a monocistron *in vivo* (Scott et al., [@B22]) and a promoter-trap study identified a unique promoter, P*ivi66*, within *cag7* (Castillo et al., [@B9]). Analysis of our *H. pylori* *cat-T-caglibmG27-tnpR* library in rodents has the potential to identify additional *in vivo* induced *cag* PAI promoters.
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###### 

**Open reading frame primer pairs selected for real time RT-PCR**.

  Primer   Strain^a^   Forward primer (5′-3′)          Reverse primer (5′-3′)
  -------- ----------- ------------------------------- -----------------------------
  Cag1     U           GCTATGGGGATTGTTGGGATAA          GCTTCAGTTGGTTCGTTGGTAA
  Cag2     A           TGTAAGGGCGTTTTACGAGAA           TTTGGGATATTTAGGATTTTGTGAA
  Cag2     B           ACTGTAAGGGCGTTTTACGAGAA         GGGCGTGTTTTCACAATGTAA
  Cag2     C           GAATTTGTCCAATAGGGGATTTTTA       AACAGAGAGATTGCCTTTTTTTGTA
  Cag3     A, C        GACACCTTGAATGTGAATGACAAA        GTTGTAATACCCATTGACTTGCTCTAA
  Cag3     B           AAACAAGAGCGATGGGAACTTA          TAGGGGCGAACACACTTCA
  Cag4     A, B        GCGAGAAAAATCCCTTAAAGACA         GTGTTTCATTCCCCCATTGTAA
  Cag4     C           CCATCACTTTCAAGCAATACGA          GAGCGTTTTAGAATAGGTAGGGTAGAA
  Cag5     A, C        CGGACTAGAGATATAGGAGCGAATAA      GCCACTGCCTGCCTACAA
  Cag5     B           TAGTAGGAGCAATCAAGCCAATAAA       TAGGGACATAGGAGCGAATAAAAA
  virB11   U           CCTCTAAGGCATGCTACTGAAGAA        TCGCTAAATTGCTGCTCAAAA
  Cag6     U           GAAAGCACGTATCAAAAATGAACTAA      CAGATAAGAAGCCACTAGGTCTGAA
  Cag7     U           AAGTCAGAAGAAATAACTGACGACTCTAA   TCACGATAAGAACAGCGACTACAA
  Cag8     U           AGCAATGAACAGATTATCAACAAAGA      GTAGTAGTTGTAGTTTCTAGGCACGG
  Cag9     U           TCTCATTGTTCCTAATTGGTTGAAA       CTTGTGGCTAATGGTGTGCTAA
  Cag10    U           AACGAAGAAGTCTTGATTGATGAAA       CTGTGTATCGATCAATGCCATAA
  Cag11    U           CACCTAGCAACTCACAGAGCAA          CCCACCCATACACAATCCTAA
  Cag12    A, C        TGTTTTAATCGGTGCGACAA            GAGCGTAATCTTTTTAGAATGGTGAA
  Cag12    B           CAAACTCAAAGACACACCATTCA         TTGTTGTTGGGATTATCATTGTAGTTA
  Cag13    U           AATAACATGCGAAAACTCTTCTCAA       CTCCATAGTCTCACTCTCAAGCAA
  Cag14    U           ACGCATTAGAGATCCGAACAA           CCATTCTTCAACACTTCTGCCATAA
  Cag15    U           CAGGGGTGATTTTAGTTTATCCAA        TATGCTGAGAGAAACGAGTAGCAA
  Cag16    U           GAAGAAGTGGCTGCAAAAGAA           CATAGGCATAAGGGTTAGGAAGAA
  Cag17    A, C        TCAAAGACATGACGACGAAGAA          GCTCTTGCCCTATCATTTCGTAA
  Cag17    B           TCGCTCTTTATTCTTTGGTTGTTTA       TGCTCTACTCTCGCCCTATCA
  Cag18    U           CCAACCAACAAGTGCTCAAAAA          TCAATAACGCTAAATCTCCTCTCAA
  Cag19    A, C        GACTTTTTGTGGTTTGTCTCTGAA        CGCCAAGCAAGATGTCTGAA
  Cag19    B           GAATGGCTTTTTCTTTGGCA            TTTTTGTGGCTTGTCCTTGAA
  Cag20    U           GCTGCTAACCAACAATACAACCAA        CTAAGATACCGCTCATCATTTCAA
  Cag21    U           GGGGCTTGTTTCTAGAGATCAACTAA      GAAAGGATTGTTTGGACCGTAA
  Cag22    A           CTTGCCCATCGTTTATTTCCTTA         ACCTTACCGCTCTTTATGATTTTTCTA
  Cag22    B, C        TTTATGTTTATGCTTACTTCATGCTAGAA   CGCTCATATCAATCTGAATCCAA
  Cag23    U           GCTAGTCATAGAGCAAGAGGTTCAAAA     CACAATAACAATCGCTACAATCAAA
  Cag24    U           GTATGGGTTAGCAAATGACGATAAA       TTAAGGACTCTATTGACAATCACGAA
  Cag25    U           CAAGAATCACTGACAGCTACAAGAA       ATACCGCCTGCCACCGCTAA
  Cag26    U           ATAAAGCGATCAAAAATCCTACCAA       GGGGGTTGTATGATATTTTCCATAA

*^a^Strain specificity: A-26695, B-J99, C-J166, U-universal*.

###### 

**Intergenic primer pairs selected for real time RT-PCR**.

  Primer pair^a^   Strain^b^   Forward primer (5′-3′)           Reverse primer (5′-3′)
  ---------------- ----------- -------------------------------- -------------------------------
  Cag1/2           A           CGTTACCAACGAACCAACTGA            TCATTGAGCCATTTATTTCTCGTAA
  Cag2/3           A           GTGTAAATGGACTGCTAGTGTGGA         AGCGATACAGCGGTTGCTA
  Cag2/3           B           ATGTCCCAAATGCAACAGATTAA          CGGCTTCACTTATTTCTTTAGCATAA
  Cag2/3           C           TTCACTCCCAATGAGTTTTTTACA         CGGCTTCACTTATTTCTTTAGCATA
  Cag3/4           A           GTGTGGTTATGAGAGCGTTCAA           ATTTTTCTCGCCTGTTGTTCAA
  Cag3/4           B           AACTGCTTTCACCACTAAGGGA           GGATTTTTCTCGCTTGTTGTTCA
  Cag3/4           C           TGTGTGGTTATGAGAGCGTTCA           GGTGAGATTTTCGTATTGCTTGA
  Cag4/5           A           TTCTCAAGTGCGATATAACGAGTAGA       TCTTTAGTGCCTGTGGGTTCAA
  Cag4/5           B           CTAAGAGCGATGGTTGGCAA             AAAATATGATCTTTGTCTTGCATGAA
  Cag4/5           C           GGGGAATGAAACACAACCCTAA           GAAGGCAAAAAGCCTATTCCAA
  Cag5/virB1 1     U           ACCCTTTCTTTCAGCCCATCTATAA        TGTCCATATCAACCACCACAA
  virB11/Cag 6     U           AGGATTTAATGCCGCTTCTTTTAA         CAATGAGATGGTCCAAGATATAGGGA
  Cag6/7           U           GTTCCATTGCTGTTTCCTTTCA           AATCACCACAAGCCCCAAA
  Cag7/8           A, B        GGTGAATCTTGTTGGGCTTTTTTA         AGGATTGAGATGGTATAGAGTTAATGAAA
  Cag7/8           C           TTCAAGTTTATCGTTTTCTTCATTCA       ATGGTATAGAGTTAATGAAATTGCAGAA
  Cag8/9           U           AATAACCAAGACAGAAACAGCCAA         GATGGTAGCAGAATGGATAGAGAAA
  Cag9/10          U           AATAGCTTTCAACCAATTAGGAACAA       AACTCTTCTCAAGAAAATCTTATCATCAA
  Cag10/11         U           CCCAACCAAATTTTCATCAATCA          GTTTGAAGCAATCCGCTACTTACA
  Cag11/12         A, B        AAACAAGGCGGTGCAGAA               GGTGTGTCTTTGAGTTTGTCATTTAA
  Cag11/12         C           GCTTCATAGGTATGGGCTATTTGA         TGTTTCACCACTTTTTTCGCATA
  Cag12/13         U           AAATCAGAAGTTTGCTCAGTGGTAA        CGCTAATCTAAAAACCATTGAACAA
  Cag13/14         U           AGCGGTCATAATTCAAAGAGCAA          CAACAAGGCAATAGATTACTAGCT GAA
  Cag14/15         U           ACCAATCGCAAACAAATCAAA            GATATGGTGGTGGTTTTCCAA
  Cag15/16         A, C        AATACCAACAAGCCGCATACAA           CTCCAAACGCAACCAATGA
  Cag15/16         B           AATACCAACAAGCCGCATACAA           TGGATCAGATTAGGGATTATTGGAA
  Cag16/17         U           CGATCCTATGATGAGCGACAA            GATAGCGTTTAAGCCCCCATAA
  Cag17/18         U           GCTCTAAATCTGAACTGCCCAATA         GAACAAAGTAAGCGACAATACCTACA
  Cag18/19         U           GGCTAGTGGTTGAAAAAATCTCATCTA      AAAGAGAAACGACAGCAAGAAACA
  Cag19/20         U           ATAACGCCATTAGCCCCTTTTAA          GGGTGCAAACTAAAATAATCGTGAA
  Cag20/21         A, B        GATTAGTAAATCCCACAACAATAGGAATAA   TTTTTACCACCGATCTTAGGGTATTAA
  Cag20/21         C           GCGGTCATTTGCGGATTAGTA            GGCGATTACGGTCCAAACA
  Cag21/22         U           AGCGTTAAACATGCCAATGATAA          GATATGAGCGTTGAAGCTAAAAAGAA
  Cag22/23         U           TCACCTTCCATTTCTTCTTCTATGAA       GTTTTAATTTGAGGGGCATTCCTA
  Cag23/24         U           CGCTTTTGAACCTCTTGCTCTA           TCAGCACGACCAACAAACAA
  Cag24/25         U           CATACGAACTGAAAACAACGAGACTTA      ATATTGGCGAGAGTGGAGGA

*^a^One primer was in the intergenic space and the other was sometimes located in an adjacent gene. ^b^Strain specificity: A-26695, B-J99, C-J166, U-universal*.

###### 

**Primer pairs used to construct promoter knockouts**.

  Primer pair   Forward primer (5′-3′)                  Reverse primer (5′-3′)
  ------------- --------------------------------------- -------------------------------------
  Cag1-U        TATGCGGCCGCCGCTTTCACTAACGCTTCCACTA      GCACTGCAGGCGCAAGAATACAGCATTGGGC
  Cag1-D        AGTGGATCCATGGCTGACACAATCAATACAACTG      CTGCTCGAGCTTCATCATCCACATTCTTGTTGAAG
  Cag10-U       ACACTCGAGTCCACTCACATCATAGCCATGCA        ACACTGCAGCCTAGCAACTCACAGAGCAATGA
  Cag10-D       ACAGGATCCGCCCTTGATAGATTGGCTAAACTCA      ACAGCGGCCGCCGACAAAAGCAAGCATGGCTGTA
  Cag11-U       ACAGCGGCCGCCGACAAAAGCAAGCATGGCTGTA      ACAGGATCCGCCCTTGATAGATTGGCTAAACTCA
  Cag11-D       ACACTGCAGCCTAGCAACTCACAGAGCAATGA        ACACTCGAGTCCACTCACATCATAGCCATGCA
  Cag16-U       AACCTCGAGGAGTCTTACTTGTGGGACACTC         AACGGATCCATAGGCTGTTCAATATCAGCTCTATC
  Cag16-D       AACCTGCAGAGCTCATTGGTTGCGTTTGGAG         AACGCGGCCGCTTCTCTCAAAGCGTTAGTGGCG
  Cag21-U       AACGCGGCCGCAACCTTATCACAGGAGATATGAACC    AACGAGCTCTAGCATTGAGACTATCTATGAGACC
  Cag21-D       AACGGATCCGCTTGGTGTCTTATCATTGGCATG       AACCTCGAGGATGTAATCAAGGTAAGTCAAATGCG
  Cag25-U       AGTGCGGCCGCCTTGTCTAAAGCCAAATTCATGCC     AGTCTGCAGCCTTCCAATACAGCTTGATTGTCA
  Cag25-D       AGTGGATCCCGCACAAGAATCACTGACAGCTACAAGA   AGTCTCGAGGAGAATAGTTGTTAGTAAGGATCAC
  CAT-1^a^      AAC[GGATCC]{.ul}GCGGACAACGAGTAAAAGAG    AAC[CTGCAG]{.ul}GCAGGACGCACTACTCTCG
  CAT-2^b^      AAC[GGATCC]{.ul}GCGGACAACGAGTAAAAGAG    AAC[GAGCTC]{.ul}GCAGGACGCACTACTCTCG
  CAT-3^c^      AAC[CTGCAG]{.ul}GCGGACAACGAGTAAAAGAG    AAC[GGATCC]{.ul}GCAGGACGCACTACTCTCG

*U, upstream arm; D, downstream arm*.

*^a,b,c^Knockouts were constructed with amplification of the CAT gene using primer pairs CAT-1 (*cag1*, *cag10*, *cag25*), CAT-2 (*cag21*), or CAT-3 (*cag11*, *cag16*), which differed only in the 5′ restriction sites (underlined)*.

###### 

**Primer pairs used to generate amplicons for *cag* PAI libraries**.

  Oligo upstream   Sequence                                  Oligo downstream   Sequence
  ---------------- ----------------------------------------- ------------------ ------------------------------
  **J166**         **J166**                                                     
  MWG268           cgctcaaacctgaaagatcaa                     MWG653             taggggcgaacacacttca
  MWG607           ctaaagagaccaagaaagaggctaaa                MWG18571           cactatggagacttgcggaaa
  MWG406           ctaagagcgatggttggcaa                      MWG463             cctctaaggcatgctactgaagaa
  MWG103           tggacaatcatatcaatcaaatcttta               MWG1198            gtttgagcgatgaagagaagc
  MWG988           acaagagggagctttttaatcaca                  MWG19145           tctcattgttcctaattggttgaaaa
  MWG1008          aacgagctccatagaatctttgaaccaatctag aacga   MWG028             tgcggttttgttttttggattagaa
  MWG410           aatgtaagtagcggattgcttcaa                  MWG19155           acgcattagagatccgaacaa
  MWG416           agcggtcataattcaaagagcaaa                  MWG657             tgctctactctcgccctatca
  MWG063           cagcttcaattttgatacccaatc                  MWG475             gactttttgttgtttgtctctgaa
  MWG476           cgccaagcaagatgtctgaa                      MWG436             gttttaatttgaggggcattccta
  MWG18880         ctagcatgaagtaagcataaacataaactaa           MWG17626           gctaatgacatccacttaaatccaaa
  MWG734           aacctcgagaccttgagatacaagtcttttctgttg      MWG807             gacagattttcaaagacagcttca
  MWG17643         aacctcgaggctttactttatggtgagccataac        MWG9165            ttagaataatcaacaaacatcacgccat
  **G27**          **G27**                                                      
  A-cag            gcgagcggcgatgtgatctggc                    B-cag              ggaacgccaccgttggttataaagac
  C-cag            gattggatcgtaatgcttcaaatcc                 MWG9165            ttagaataatcaacaaacatcacgccat
  D-cag            cctgtatctgtccctagctc                      MWG807             gacagattttcaaagacagcttca
  F-cag            ggactccattgttcctaatgg                     E-cag              gatgatggggtgatccttactaacaac
  Q-cag            gacccgttagggaattataatc                    R-cag              cctatcaataacaacataagcgag
  O-cag            cagagcagtcataattcaaagagc                  P-cag              tgctctgctctcgccctatca
  M-cag            gtaaggtagcggattgcttcaaacaag               N-cag              cacgcattagagatccgaacaagc
  L-cag            gctttaagactctctttagcttc                   I-cag              gatgggaaattgagcatgactg
  J-cag            gaagctaaagagagtcttaaagc                   K-cag              gtaaagaaccgagtttggtaaac
  G-cag            ccttagcaccattcctgccataacc                 H-cag              gaaggaagctcaatgagattgtc

*Several additional oligonucleotide pairs were required to amplify the entire *H. pylori* G27 strain *cag* PAI region, due to poor or no amplicon presence in some PCR reactions*.

###### 

**Putative promoter sequences that direct expression of the reporter *tnpR***.

  Promoter   Length (nt)   Sequence
  ---------- ------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  I          244           GATCAAAAAAATCAAAACAAAAATAACGATTGAGTGGCGTTAATGCGCTAGAATAGTGCTAAAAATAAGAATAAAGGAATCAAAAGTATGAAAACGAATTTTTATAAAATTAAATTACTATTTGCTTGGTGTCTTATCATTGGCATGTTTAACGCTCCGCTTAACGCTGACCAAAACACTGATATAAAAGATATTAGTCCTGAAGATATGGCACTAAATAGCGTGGGGCTTGTTTCTAGAGATC
  II         38            GATCGTTTGACAATTTTAAATTCTCCTGTGTATCGATC
  III        91            GATCTGTTGCTTTATTGTCAAAAAGCCATTGAAATTCACCATTGGTTGATTTGCAAAAA GGCGCTAATCGCGCGACAAGCCCATTAGGATC
  IV         104           GATCCCAATGCCCACACGCTTGATAAGGGAGCGTCAATTGATGAGAACAAGCTTTTT GAACAACAAAAACGCGCGTATTTCAACTACGCCAACGATGTGATC
  V          71            GATCAGCTTGGGTTTGTTTCTGCTTGTTTTTAGGTTTCAACCTGAGACGATTAAAAAA TACATCAAAGATC
  VI         314           GATCCTAAATATCCCAAATGCAATGGATTGATGAAAAGAAAAAAGAATTTCAAAAACAATGAGTTTTTTACAGCTGCATTACTTACCTTAAATGCAATGGAATTTTGTCTCTATATCAATTCTGAAAAAAAAGGAAACTAATGTTTAGAAAACTAGCAACCGCTGTATCGCTCATAGGCTTACTAACCTCTAACACTCTTTATGCTAAAGAAATAAGTGAAGCCGATAAGGTCATTAAGGCCACTAAAGAAACTAAAGAGACCAAGAAAGAAGTTAAACGACTCAAAAAAGAAGCTAAACAGCGCCAACAGATC
  VII        234           GATCAAGAGATTATCAAAGGAAGCAAAAAAAAATACATTATTAGTGGCATTGTAGTCGCTGCTCTTATCGTGATTATTTTATTTTCTAGAAGCATTTTTCACTACTTTATACCTTTGGAAGATAAAAGCTCTCGTTTTAGCAAAGACAGGAATCTTTATGTCAATGATGAAATCCAAATAAGGCAAGAGTATAACCGATTGCTGAAAGAACGGAATGAAAAAGGCAATATGATC
  VIII       635           GATCCATGATGCTCTGTTGTATCGTTCATGAAATTCCTTTCAAGAATTAAATTGAGAAATTGTTTTGATATTATACCATTCTCTCTCTGAGTTGTGATTGTCTTATCTCTTTGAATTAGGCGCTTCTAAAATTTCATTACTGATTACGACTGCTTACTTATTGCTCTTACTTTTTGAGTTGCATCGTGTTTCATCTTGCTTCTTGTTTGAAGCAATCCGCTACCTTACATTTATTATAAGGAATCTTTGTTCAACGCCTTATCCAAAAAGGTTTTTATTAAAGGTTTTTTCAAATATATATTTTTACAGAAATTTTGCTATACTATAACTGAAATTGTTTTAAGGAGTTTTTGATGAAAAAATTTCTCAAGTATTTCTCAAGTTTTGCAACCAACAAACCAATAACTAAACAATAAAGCTGTCGCATGTTAGGGAAAAAAAACGAGGAAGTCTTGATTGATGAAAATTTGGTTGGGGGTGTGATAGCCCTTGATAGATTGGCTAAACTCAATAAGGCCAATAGGACTTTCAAAAGGGCTTTTTATCTCTCTATGGCGCTCAATGTCGCCGCTGTAACGAGTATTGTGATGATGATGCCTTTGAAGAAAACGGATATATTTGTTTATGGCATTGATC
  IX         132           GATCATAGTGCCGTTCATGTTCCATACATCTTTGGCTACAACCCCACTCACTATACCT GTGAGAGTGGCATCTACTTTAGAAGTCAGAGTGATTTCAATAGGGGTGTATTGCGCT AAAACAAATGTGGGATC
  X          269           GATCTATGTTTAAAGGCTAGCCGCTTTATTCTTGTGTTACAATTACAAATATTTTTTAAGAGGAATTGTTGATGGGGCGGGCATTGTTTAAAAAAATTGTTGGCTGTTTCTGTCTTGGTTATTTATTTTTATCTAGCGTAATAGAAGCAGCACCTGACATTAAAAATTTTAATCGTGGTAGGGTGAAAGTGGTGAATAAGAAGATTGCTTATTTGGGAGATGAAAAACCTATTACGATTTGGACTTCATTAGACAATGTTACTGTGATC
  XI         419           GATCTTTGATGTATTTTTTAATCGTCTCAGGTTGAAACCTAAAAACAAGCAGAAACAAACCCAAGCTGATCAGAGTGAGAATAAAGCTCCATTTTAAGCAACTCCATAGACCACTAAAGAAACTTTTTTTGAAGCTGTCTTTGAAAATCTGTCCTATTGATTTGTTTTCCATGTGAATCACAAACGCTTAATTGCAAATATATACTTTATGGTAAGCATGACACACAAACCAAACCATTTTTAGAACGCTTCATGCACTCACCTTGATTCCAACTATATTTAAGCATTGCATTTGATTTATTCTTGAAGGTTCATTTCTTATTTCTTTTCTTTGTTAAAATTCGTTCATTTTAGCAAATTTTTGTTAATTGTGGGTAAAAATGTGAATCGTTCCTAGCCTTTAGACGCCTGCAACGATC
  XII        54            GATCCCTAGAACAAAGTAAGCGGCAATACCTACAAGAAAGGCAATCAAGTAAGATC
  XIII       68            GATCCAATCATTGAAAAAATCTTTGATGAAAAGGGTAAAGAAATGGGATTGAATGTAG AATTACGATC
  XIV        70            GATCCTACTGGTGGGGATTGGTTGGATATTTTTCTCTCATTTATATTTGACAAAAAACA ATCTTCCGATC

###### 

**Key to *cag* PAI gene names**.

  26695 ORF   Gene number           Gene name      T4SS homolog
  ----------- --------------------- -------------- --------------
  HP0520      *cag1*                *cagC*         
  HP0521      *cag2*/hypothetical   Hypothetical   
  HP0522      *cag3*                *cagA*         
  HP0523      *cag4*                *cagy*         VirB1
  HP0524      *cag5*                *cag*β         VirD4
  HP0525                            *cag*α         VirB11
  HP0526      *cag6*                *cagZ*         
  HP0527      *cag7*                *cagY*         VirB10
  HP0528      *cag8*                *cagX*         VirB9
  HP0529      *cag9*                *cagV*         VirB6
  HP0530      *cag10*               *cagW*         VirB8
  HP0531      *cag11*               *cagU*         
  HP0532      *cag12*               *cagT*         VirB7
  HP0533      Hypothetical          Hypothetical   Hypothetical
  HP0534      *cag13*               *cagS*         
  HP0535      *cag14*               *cagQ*         
  HP0536      *cag15*               *cagP*         
  HP0537      *cag16*               *cagM*         
  HP0538      *cag17*               *cagN*         
  HP0539      *cag18*               *cagL*         VirB5
  HP0540      *cag19*               *cagI*         
  HP0541      *cag20*               *cagH*         
  HP0542      *cag21*               *cagG*         
  HP0543      *cag22*               *cagF*         
  HP0544      *cag23*               *cagE*         VirB3/VirB4
  HP0545      *cag24*               *cagD*         
  HP0546      *cag25*               *cagC*         VirB2
  HP0547      *cag26*               *cagA*         

[^1]: Edited by: D. Scott Merrell, Uniformed Services University, USA

[^2]: Reviewed by: Jeong-Heon Cha, Yonsei University, South Korea; Hilde De Reuse, Institut Pasteur, France
